Edmonton Organ Transplant Company Tevosol Secures Financing
EDMONTON, AB--(Marketwired - June 29, 2016) - Medical device company Tevosol is one step closer to improving the lives of patients awaiting organ transplants after securing $2 million in financing. This TEC Edmonton client and University of Alberta spinoff company has designed a medical device that keeps critical organs such as hearts and lungs viable for transplant longer.
